John C Schmitz Selected Research

John C Schmitz Research Topics

Disease

19	Neoplasms (Cancer) 04/2024 - 02/2002
10	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2004
9	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2002
2	Lung Neoplasms (Lung Cancer) 11/2023 - 10/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 02/2002
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 08/2012
1	Pancreatitis 12/2011
1	Adenocarcinoma 05/2011
1	Carcinoma in Situ 05/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2011
1	Melanoma (Melanoma, Malignant) 09/2009
1	Nevus (Nevi) 09/2009
1	Mesothelioma 02/2002

Drug/Important Bio-Agent (IBA)

6	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 02/2002
5	Small Interfering RNA (siRNA)IBA 04/2013 - 02/2004
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2007
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2006
3	Thymidylate SynthaseIBA 01/2011 - 02/2002
2	2-bromolysergic acid diethylamide (BOL)IBA 01/2023 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2019 - 09/2009
2	protein kinase DIBA 03/2015 - 05/2014
2	Protein Isoforms (Isoforms)IBA 05/2014 - 05/2011
1	FR 901464IBA 04/2024
1	meayamycinIBA 11/2023
1	venetoclaxIBA 11/2023
1	QuassinsIBA 01/2023
1	snake venom protein C activatorIBA 01/2023
1	ARQ 197IBA 10/2021
1	Bevacizumab (Avastin)FDA Link 10/2021
1	ElectrolytesIBA 10/2021
1	bruceantinolIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018
1	Gemcitabine FDA Link 09/2017
1	veliparibIBA 09/2017
1	Indicators and Reagents (Reagents)IBA 01/2016
1	cyclopropaneIBA 12/2015
1	disorazole C1IBA 12/2015
1	regorafenibIBA 03/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015
1	olaparibIBA 01/2015
1	DNA Repair EnzymesIBA 01/2015
1	CRT 0066101IBA 05/2014
1	kb-NB142-70IBA 05/2014
1	Etoposide (VP 16)FDA LinkGeneric 10/2013
1	Carboplatin (JM8)FDA LinkGeneric 10/2013
1	Histone Deacetylase InhibitorsIBA 10/2013
1	PanobinostatIBA 10/2013
1	NucleosidesIBA 04/2013
1	Messenger RNA (mRNA)IBA 08/2012
1	CeruletideIBA 12/2011
1	CytokinesIBA 12/2011
1	Ethanol (Ethyl Alcohol)IBA 12/2011
1	Matrix Metalloproteinases (MMPs)IBA 05/2011
1	CortactinIBA 05/2011
1	Adenosine Triphosphatases (ATPase)IBA 05/2011
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 05/2011
1	Mitogen-Activated Protein KinasesIBA 09/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2009
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 05/2008
1	Complementary DNA (cDNA)IBA 04/2006
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2006
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2006
1	LuciferasesIBA 03/2004
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2004
1	TubulinIBA 02/2004
1	ThymidineIBA 07/2003
1	triphosphoric acid (triphosphate)IBA 07/2003
1	CarbamatesIBA 02/2002
1	Capecitabine (Xeloda)FDA Link 02/2002
1	Pemetrexed (MTA)FDA Link 02/2002
1	EnzymesIBA 02/2002
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2002
1	Folic Acid AntagonistsIBA 02/2002
1	ZD 9331IBA 02/2002
1	raltitrexed (D 1694)IBA 02/2002
1	Leucovorin (Folinic Acid)FDA Link 02/2002

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2023 - 02/2002
4	Therapeutics 01/2019 - 02/2002